Found: 15
Select item for more details and to access through your institution.
Targeting Nuclear Receptor Coactivator SRC‐1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD‐L1.
- Published in:
- Advanced Science, 2024, v. 11, n. 33, p. 1, doi. 10.1002/advs.202310037
- By:
- Publication type:
- Article
Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study.
- Published in:
- Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2024.1313610
- By:
- Publication type:
- Article
Comparative mitochondrial proteomic analysis of hepatocellular carcinoma from patients.
- Published in:
- Proteomics - Clinical Applications, 2013, v. 7, n. 5/6, p. 403, doi. 10.1002/prca.201100103
- By:
- Publication type:
- Article
A positive feedback loop between ID3 and PPARγ via DNA damage repair regulates the efficacy of radiotherapy for rectal cancer.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10874-7
- By:
- Publication type:
- Article
siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
- Published in:
- Oncology Reports, 2016, v. 35, n. 4, p. 1933, doi. 10.3892/or.2016.4602
- By:
- Publication type:
- Article
Inhibitor of DNA-binding protein 1 knockdown arrests the growth of colorectal cancer cells and suppresses hepatic metastasis in vivo.
- Published in:
- Oncology Reports, 2014, v. 32, n. 1, p. 79, doi. 10.3892/or.2014.3172
- By:
- Publication type:
- Article
UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12887-2
- By:
- Publication type:
- Article
UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12887-2
- By:
- Publication type:
- Article
Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-023-11790-6
- By:
- Publication type:
- Article
Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 3, p. 995, doi. 10.3892/ijo.2014.2513
- By:
- Publication type:
- Article
Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 6855, doi. 10.2147/CMAR.S207167
- By:
- Publication type:
- Article
Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention.
- Published in:
- Scientific Reports, 2016, p. 22388, doi. 10.1038/srep22388
- By:
- Publication type:
- Article
Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/3794021
- By:
- Publication type:
- Article
RUNX3/H3K27me3 Co-Expression Defines a Better Prognosis in Surgically Resected Stage I and Postoperative Chemotherapy-Naive Non-Small-Cell Lung Cancer.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/5752263
- By:
- Publication type:
- Article